The association of the killer cell immunoglobulin-like receptor (KIR) genotype distribution and HLA-C ligands in colorectal cancer in the eastern region of Saudi Arabia
Open Access
- 1 July 2024
- journal article
- research article
- Published by Scientific Scholar in Journal of King Saud University – Science
- Vol. 36 (6)
Abstract
Colorectal cancer (CRC) is the most common cause of cancer-related mortality globally. It ranks as the most common cancer among men and the third most prevalent among women in Saudi Arabia, especially in the eastern region. The immune system's response to cancer is significantly influenced by natural killer cells through their killer-cell immunoglobulin-like receptors (KIRs) interaction with human leukocyte antigen (HLA) molecules. Our research aimed to target a homogeneous ethnic group in the eastern region of Saudi Arabia, analyzing the distribution of 16 KIR genes and HLA-C1/C2 allotypes in 50 CRC patients and 63 healthy controls using the sequence-specific PCR amplification method. Findings revealed significantly lower frequencies of the 2DL2 and 3DL1 genes in CRC patients compared to controls (OR = 2.21; P = 0.04) and (OR = 7.46; P = 0.00009), respectively. Additionally, a higher prevalence of HLA-C2 was noted in CRC patients (84 %) versus controls (66.7 %) (OR = 2.26; P = 0.04). Conversely, the HLA-C1C2 combination showed a protective effect against CRC (OR = 0.38; P = 0.04). Our combinatorial analysis further identified specific gene combinations correlating with CRC risk or protection. Notably, the absence of KIR2DL2 combined with the presence of KIR2DS2 emerged as a significant risk factor, while various combinations involving KIR2DL2 and/or KIR2DS1 with HLA-C ligands were associated with either increased susceptibility or protection. The study underscores the protective role of KIR2DL2 against CRC in Saudi Arabia's eastern region and suggests that the absence of KIR2DL2, especially when KIR2DS2 is present, might increase CRC risk. This research contributes to understanding genetic influences on CRC susceptibility, emphasizing the potential of KIR and HLA interactions as biomarkers for CRC risk assessment.Keywords
Funding Information
- King Saud University (RSP-2024/35)
This publication has 35 references indexed in Scilit:
- Activating and inhibitory killer cell immunoglobulin like receptors (KIR) genes are involved in an increased susceptibility to colorectal adenocarcinoma and protection against invasion and metastasisImmunobiology, 2019
- KIR genes and HLA class I ligands in a Caucasian Brazilian population with colorectal cancerHuman Immunology, 2017
- Association of the genetic diversity of killer cell immunoglobulin-like receptor genes and HLA-C ligand in Saudi women with breast cancerImmunogenetics, 2016
- KIR and HLA under pressure: evidences of coevolution across worldwide populationsHuman Genetics, 2015
- HLA-Cw polypmorphism and killer cell immunoglobulin-like receptor (KIR) gene analysis in Korean colorectal cancer patientsInternational Journal of Surgery, 2014
- Analysis of KIR gene frequencies and HLA class I genotypes in breast cancer and control groupHuman Immunology, 2013
- Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumorsHuman Immunology, 2010
- KIR haplotype content at the allele level in 77 Northern Irish familiesImmunogenetics, 2007
- Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002Immunogenetics, 2003
- Inhibitory MHC class I receptors on NK and T cells: a standard nomenclatureImmunology Today, 1996